ClinicalTrialsFinder

Triple Hit Lymphoma Clinical Trials in Santander, Cantabria

1 recruitingSantander, Cantabria, Spain

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies

Chronic Lymphocytic Leukemia (CLL)High Grade B-Cell Lymphoma, Not Otherwise SpecifiedMultiple Myeloma (MM)+3 more
IDP Discovery Pharma S.L.37 enrolled11 locationsNCT05908409